Nationwide Medicare Licensed DME Company for Sale – CGM Specialty | 400+ Active Patients | High Growth Segment
A rare opportunity to acquire a fully established, multi state Durable Medical Equipment (DME) company with a strong niche focus in Continuous Glucose Monitoring (CGM) — one of the fastest growing segments in diabetes care.
Headquartered in New Jersey and licensed with Medicare in all 50 states, Puerto Rico, and Guam, this business is built for scale and positioned for immediate expansion.
The company currently services 400+ active recurring revenue patients and continues to grow organically month over month.
Key Investment Highlights
• Nationwide Medicare licensing (50 states + Puerto Rico + Guam)
• High demand CGM product focus with strong reimbursement
• 400+ active patients generating predictable recurring revenue
• Consistent growth — averaging 16 new patients per month
• Efficient, streamlined operations ready for scale or integration
• 2025 Gross Revenue: $829,000
• Strong foundation for expansion into RPM, diabetes management programs, or broader DME categories

Asking Price: $1,100,000
Ideal Buyer Profile
Perfect for:
• Strategic healthcare operators
• Existing DME companies seeking national expansion
• Investors entering the CGM / diabetes care / remote patient monitoring space
• Organizations looking for a turnkey, compliant, Medicare licensed platform

Additional financials and operational details are available upon request.
Serious inquiries only. NDA required.